Summit Securities Group’s Johnson & Johnson JNJ Stock Holding History

Summit Securities Group’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-35,000	Closed	-$5.49M	–	699
2023 Q4	$5.49M	Sell	35,000 -48,400	-58%	-$7.42M	0.5%	34
2023 Q3	$13M	Buy	83,400 +78,800	+1,713%	+$13M	1.34%	15
2023 Q2	$761K	Buy	+4,600	New	+$742K	0.1%	115
2022 Q1	–	Sell	-3,000	Closed	-$513K	–	1216
2021 Q4	$513K	Buy	3,000 +2,960	+7,400%	+$485K	0.02%	368
2021 Q3	$646K	Buy	40 +10	+33%	+$1.71K	0.05%	349
2021 Q2	$494K	Sell	30 -25	-45%	-$4.14K	0.04%	391
2021 Q1	$904K	Buy	55 +15	+38%	+$2.43K	0.1%	215
2020 Q4	$630K	Buy	+40	New	+$5.9K	0.05%	306
2020 Q3	–	Sell	-40	Closed	-$563K	–	434
2020 Q2	$563K	Buy	+40	New	+$5.83K	0.07%	219
2020 Q1	–	Sell	-875	Closed	-$12.8M	–	382
2019 Q4	$12.8M	Buy	+875	New	+$119K	0.97%	21
2019 Q1	–	Sell	-110	Closed	-$1.42M	–	285
2018 Q4	$1.42M	Buy	+110	New	+$15.3K	0.12%	106
2016 Q4	–	Sell	-558	Closed	-$6.59M	–	292
2016 Q3	$6.59M	Buy	558 +348	+166%	+$42.2K	2.22%	8
2016 Q2	$872K	Buy	+210	New	+$23.9K	0.47%	50

Other funds holding JNJ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Summit Securities Group's JNJ Position: Q1 2026 in Review

Summit Securities Group reduced its Johnson & Johnson (JNJ) stake by 69% in Q1 2026, selling an estimated $807K and leaving 1,526 shares worth $373K. The position accounts for 0.05% of the portfolio, ranked #171.

Summit Securities Group first reported a position in JNJ in Q2 2013 and has held it in 39 quarters since. The position peaked at $15M in Q2 2013. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

Summit Securities Group held 1,526 shares of Johnson & Johnson worth $373K as of Q1 2026.
Summit Securities Group sold 3,466 Johnson & Johnson shares in Q1 2026, an estimated $807K.
Johnson & Johnson made up 0.05% of Summit Securities Group's portfolio in Q1 2026, its #171 holding.
Summit Securities Group first reported a position in Johnson & Johnson in Q2 2013 and has held it in 39 quarters since.
Summit Securities Group's Johnson & Johnson position peaked at $15M in Q2 2013.
4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Summit Securities Group's 13F filing for Q1 2026, filed 30 Apr 2026.